| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 5.330 | 1.939 | 2.352 | 4.584 | 4.201 | 2.826 |
| Total Income - EUR | - | - | - | 0 | 5.330 | 2.204 | 4.040 | 4.952 | 4.201 | 2.826 |
| Total Expenses - EUR | - | - | - | 80 | 4.250 | 2.510 | 4.319 | 3.634 | 3.355 | 3.528 |
| Gross Profit/Loss - EUR | - | - | - | -80 | 1.079 | -306 | -280 | 1.317 | 846 | -702 |
| Net Profit/Loss - EUR | - | - | - | -80 | 919 | -363 | -280 | 1.241 | 713 | -702 |
| Employees | - | - | - | 0 | 1 | 0 | 0 | 1 | 0 | 0 |
Check the financial reports for the company - Speranta Tratamente S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 1.463 | 2.581 | 1.361 | 225 | 1.408 | 730 | 56 |
| Current Assets | - | - | - | 43 | 216 | 2.672 | 947 | 27 | 1.382 | 1.343 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 44 | 0 | 59 | 59 |
| Cash | - | - | - | 43 | 216 | 2.672 | 903 | 27 | 1.324 | 1.284 |
| Shareholders Funds | - | - | - | -37 | 883 | 504 | -594 | 646 | 1.358 | 648 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.542 | 1.914 | 1.794 | 1.756 | 779 | 746 | 741 |
| Income in Advance | - | - | - | 0 | 0 | 1.736 | 9 | 9 | 9 | 9 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4932 - 4932" | |||||||||
| CAEN Financial Year |
4932
|
|||||||||
Comments - Speranta Tratamente S.r.l.